275 related articles for article (PubMed ID: 15801226)
1. [Human fascioliasis in South America].
Gorokhov VV; Sergiev VP; Uspenskiĭ AV; Romanenko NA; Vil'iavisensio A; Molchanov IA
Med Parazitol (Mosk); 2005; (1):55-8. PubMed ID: 15801226
[No Abstract] [Full Text] [Related]
2. Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt.
Esteban JG; Gonzalez C; Curtale F; Muñoz-Antoli C; Valero MA; Bargues MD; el-Sayed M; el-Wakeel AA; Abdel-Wahab Y; Montresor A; Engels D; Savioli L; Mas-Coma S
Am J Trop Med Hyg; 2003 Oct; 69(4):429-37. PubMed ID: 14640504
[TBL] [Abstract][Full Text] [Related]
3. Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru.
Marcos L; Maco V; Terashima A; Samalvides F; Espinoza JR; Gotuzzo E
Rev Inst Med Trop Sao Paulo; 2005; 47(4):219-22. PubMed ID: 16138205
[TBL] [Abstract][Full Text] [Related]
4. Eight cases of fascioliasis: clinical and microbiological features.
Dauchy FA; Vincendeau P; Lifermann F
Med Mal Infect; 2006 Jan; 36(1):42-6. PubMed ID: 16309872
[TBL] [Abstract][Full Text] [Related]
5. The first report in New Zealand of Lymnaea columella Say (Mollusca: Gastropoda) an intermediate host of the liver fluke Fasciola hepatica L.
Pullan NB
N Z Vet J; 1969 Dec; 17(12):255-6. PubMed ID: 16030663
[No Abstract] [Full Text] [Related]
6. [Epidemiology of hepatic fascioliasis (Fasciola gigantica) at the dairy farm of the Lubumbashi (Zaire) ranch. Results of a deparasitization trial. Recommendations].
Singh BB; Welu M; Makwabily Y
Rev Elev Med Vet Pays Trop; 1983; 36(3):253-7. PubMed ID: 6672883
[No Abstract] [Full Text] [Related]
7. Human fascioliasis: a case of hyperinfection and an update for clinicians.
Arauco R; Zetola NM; Calderon F; Seas C
Foodborne Pathog Dis; 2007; 4(3):305-12. PubMed ID: 17883314
[TBL] [Abstract][Full Text] [Related]
8. [Fasciolosis in Mexico. Present status and intermediary hosts].
Gómez-Agudelo T; Pérez-Reyes R; Zerón-Bravo F
Rev Latinoam Microbiol; 1978; 20(2):121-7. PubMed ID: 288113
[No Abstract] [Full Text] [Related]
9. [Distomatosis caused by Fasciola hepatica. Study of an epidemic outbreak].
Alcoba Leza M; Costilla S; Cabreros Pisonero E; Jiménez García de la Marina JM; Carro JA; López González R; Jorquera F; Martínez Ramos C; Pérez Simón MR
Rev Esp Enferm Apar Dig; 1988 Nov; 74(5):509-14. PubMed ID: 3238154
[No Abstract] [Full Text] [Related]
10. [The fasciolosis epizootic situation in Russia].
Gorokhov VV; Molchanov IA; Maĭsheva-Kolesnikova MA; Gorokhova EV
Med Parazitol (Mosk); 2011; (3):55-9. PubMed ID: 21932550
[TBL] [Abstract][Full Text] [Related]
11. [Hyperendemicity of human fasciolosis in the Mantaro Valley, Peru: factors for infection with Fasciole hepatica].
Raymundo LA; Flores VM; Terashima A; Samalvides F; Miranda E; Tantalean M; Espinoza JR; Gotuzzo E
Rev Gastroenterol Peru; 2004; 24(2):158-64. PubMed ID: 15241494
[TBL] [Abstract][Full Text] [Related]
12. New opportunities for the control of fascioliasis.
Savioli L; Chitsulo L; Montresor A
Bull World Health Organ; 1999; 77(4):300. PubMed ID: 10327707
[No Abstract] [Full Text] [Related]
13. Fasciola hepatica infection: clinical and radiological findings in pediatric patients.
Karadağ-Öncel E; Ozsürekçi Y; Ozkaya-Parlakay A; Celik M; Cengiz AB; Haliloğlu M; Ceyhan M; Kara A
Turk J Pediatr; 2012; 54(4):362-7. PubMed ID: 23692716
[TBL] [Abstract][Full Text] [Related]
14. Triclabendazole in the treatment of human fascioliasis: a community-based study.
el-Morshedy H; Farghaly A; Sharaf S; Abou-Basha L; Barakat R
East Mediterr Health J; 1999 Sep; 5(5):888-94. PubMed ID: 10983527
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the epidemiology, diagnosis, and treatment of Fasciola infection.
Webb CM; Cabada MM
Curr Opin Infect Dis; 2018 Oct; 31(5):409-414. PubMed ID: 30113327
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of human liver fluke infection].
Gorokhov VV; Sergiev VP; Uspenskiĭ AV; Romanenko NA; Kolesnikova MA; Molchanov IA; Gorokhova EV; Gur'eva SS
Med Parazitol (Mosk); 2008; (2):57-9. PubMed ID: 18561409
[No Abstract] [Full Text] [Related]
17. Fascioliasis in Puerto Rico: a review.
Hillyer GV
Bol Asoc Med P R; 1981 Mar; 73(3):94-101. PubMed ID: 6944073
[No Abstract] [Full Text] [Related]
18. [Fascioliasis as a new parasitological and medical problem in the light of laboratory studies].
Głowniak C; Bochenek W; Rogozińska E
Wiad Lek; 1983 May; 36(9):725-32. PubMed ID: 6613122
[No Abstract] [Full Text] [Related]
19. Risk factors for Fasciola hepatica infection in children: a case-control study.
Marcos L; Maco V; Samalvides F; Terashima A; Espinoza JR; Gotuzzo E
Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):158-66. PubMed ID: 16181652
[TBL] [Abstract][Full Text] [Related]
20. [Fasciola hepatica seroprevalence in the Elaziğ region].
Kaplan M; Kuk S; Kalkan A; Demirdağ K; Ozdarendeli A
Mikrobiyol Bul; 2002; 36(3-4):337-42. PubMed ID: 12838669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
